MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
0.856
+0.089 (11.55%)
Mar 5, 2026, 1:08 PM EST - Market open
MaxCyte Market Cap
MaxCyte has a market cap or net worth of $91.31 million as of March 5, 2026. Its market cap has decreased by -78.54% in one year.
Market Cap
91.31M
Enterprise Value
-5.71M
1-Year Change
-78.54%
Ranking
Category
Stock Price
$0.86
Market Cap Chart
Since the IPO on March 10, 2021, MaxCyte's market cap has decreased from $494.67M to $91.31M, a decrease of -81.54%. That is a compound annual growth rate of -28.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 81.86M | -50.49% |
| Dec 31, 2025 | 165.34M | -62.39% |
| Dec 31, 2024 | 439.69M | -9.93% |
| Dec 29, 2023 | 488.14M | -12.55% |
| Dec 30, 2022 | 558.17M | -45.87% |
| Dec 31, 2021 | 1.03B | 108.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hyperfine | 106.89M |
| Treace Medical Concepts | 94.70M |
| Neuronetics | 91.09M |
| Xtant Medical Holdings | 88.76M |
| Picard Medical | 84.02M |
| Sera Prognostics | 81.05M |
| Sensus Healthcare | 72.61M |
| QT Imaging Holdings | 71.55M |